Skip to main content

Tecan, Covaris Enter Co-marketing Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tecan announced today that it has inked a co-marketing deal with Covaris to offer Covaris' Adaptive Focused Acoustics systems with Tecan's Freedom EVO liquid handling instruments.

The firms said that the technologies have already been integrated for several applications and will be available to customers worldwide for sample preparation, compound management, and next-generation sequencing.

"AFA is gaining widespread acceptance in the compound management community for rapid thawing, mixing and dissolution of samples, as well as for DNA shearing in the exciting area of next-generation sequencing," Kevin Moore, Tecan’s director of market and application management for BioPharma, said in a statement.

Financial and other terms of the alliance were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.